Publications

MRC The Gambia Publications

Browse a collection of academic publications and research papers, contributed to by personnel from the Unit.

Epidemiology of human metapneumovirus among children with severe or very severe pneumonia in high pneumonia burden settings: the Pneumonia Etiology Research for Child Health (PERCH) study experience.

Miyakawa, R; Zhang, H; Brooks, WA; Prosperi, C; Baggett, HC; Feikin, DR; Hammitt, LL; Howie, SR C; Kotloff, KL; Levine, OS; Madhi, SA; Murdoch, DR; O'Brien, KL; SCOTT, JA G; Thea, DM; ANTONIO, M; Awori, JO; Bunthi, C; Driscoll, AJ; Ebruke, B; Fancourt, NS; Higdon, MM; Karron, RA; Moore, DP; Morpeth, SC; ... Deloria Knoll, M.

2024

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, (2024).31 3 10.1016/j.cmi.2024.10.023.

Two assumptions of the prior event rate ratio approach for controlling confounding can be evaluated by self-controlled case series and dynamic random intercept modeling.

Cheung, YB; Ma, X; MACKENZIE, G;

2024

Journal of clinical epidemiology, (2024).175, 10.1016/j.jclinepi.2024.111511.

Integrating observational and modelled data to advance the understanding of heat stress effects on pregnant subsistence farmers in the gambia.

Bouverat, C; Badjie, J; Samateh, T; Saidy, T; MURRAY, KA; PRENTICE, AM; Maxwell, N; HAINES, A; Vicedo Cabrera, AM; BONELL, A;

2024

Scientific reports, (2024).14 1 10.1038/s41598-024-74614-y.

Monkeypox virus isolation from longitudinal samples in 11 hospitalised patients.

Callaby, H; Olver, J; Emery, K; Richards, KS; Killip, M; Groves, N; Beadsworth, MB J; Price, DA; Cooke, GS; Collini, P; Cole, J; Dunning, J; Semple, MG; Baillie, JK; ISARIC4C Investigators,; Rampling, T; Houlihan, CF;

2024

The Lancet. Infectious diseases, (2024).25 1 10.1016/s1473-3099(24)00735-7.

Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms.

Citarella, BW; Kartsonaki, C; Ibáñez-Prada, ED; Gonçalves, BP; Baruch, J; Escher, M; Pritchard, MG; Wei, J; Philippy, F; Dagens, A; Hall, M; Lee, J; Kutsogiannis, DJ; Wils, E-J; Fernandes, MA; Tirupakuzhi Vijayaraghavan, BK; Panda, PK; Martin-Loeches, I; Ohshimo, S; Fatoni, AZ; Horby, P; Dunning, J; Rello, J; Merson, L; Rojek, A; ... ISARIC Clinical Characterisation Group,

2024

Heliyon, (2024).10 10 10.1016/j.heliyon.2024.e29591.

Food biodiversity and gastrointestinal cancer risk in nine European countries: Analysis within a prospective cohort study.

Huybrechts, I; Chimera, B; Hanley-Cook, GT; Biessy, C; Deschasaux-Tanguy, M; Touvier, M; Kesse-Guyot, E; Srour, B; Baudry, J; Berlivet, J; Casagrande, C; Nicolas, G; Lopez, JB; Millett, CJ; Cakmak, EK; Robinson, OJ K; MURRAY, KA; Schulze, MB; Masala, G; Guevara, M; Bodén, S; Cross, AJ; Tsilidis, K; Heath, AK; Panico, S; ... Gunter, MJ.

2024

European Journal of Cancer, (2024).210, 10.1016/j.ejca.2024.114258.

Measles-Rubella Microarray Patches Phase III Clinical Trial Framework: Proposal and Considerations.

Zehrung, D; Innis, BL; Suwantika, AA; Ameri, M; Biellik, R; Birchall, JC; Cravioto, A; Jarrahian, C; Fairlie, L; Goodson, JL; Kochhar, S; Kretsinger, K; Morgan, C; Mvundura, M; Rathi, N; CLARKE, E; Mistilis, JJ; Uwamwezi, M-C; Giersing, B; Hasso-Agopsowicz, M;

2024

Vaccines, (2024).12 11 10.3390/vaccines12111258.

Human cytomegalovirus seropositivity and its influence on oral rotavirus vaccine immunogenicity: a specific concern for HIV-exposed-uninfected infants.

LABAN, N; Bosomprah, S; Chilengi, R; Simuyandi, M; Chisenga, C; Ng'ombe, H; Musukuma-Chifulo, K; GOODIER, M;

2024

Clinical and experimental immunology, (2024).217 1 10.1093/cei/uxae029.

Higher multiplication rates ofPlasmodium falciparumin isolates from hospital cases compared with community infections.

Stewart, L; Escolar, EL; Philpott, J; Claessens, A; AMAMBUA-NGWA, A; CONWAY, D;

2024

bioRxiv (2024). 10.1101/2024.05.02.592253.

Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial.

Kositz, C; VASILEVA, H; MOHAMMED, N; Achan, J; Dabira, ED; D'ALESSANDRO, U; BRADLEY, J; MARKS, M;